Roche Diagnostics launches Covid-19 at-home test kit Ruchika Sharma28 Jan 2022 1:49 PM ISTNew Delhi: Roche Diagnostics India has recently announced that it has launched a COVID-19 'at-home' detection kit.The company said it has...
DCGI regular market nod to Covaxin, Covishield for adults Ruchika Sharma28 Jan 2022 12:06 PM ISTNew Delhi: India's drug regulator Drugs Controller General of India's (DCGI) on Thursday granted regular market approval for Covid-19 vaccines...
Covid-19: Covaxin, Covishield prices likely to be capped at Rs 275 per dose Ruchika Sharma27 Jan 2022 12:15 PM ISTNew Delhi: The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India's drug regulator,...
Medical devices, prescription drugs boost JnJ earning in Q4 Ruchika Sharma27 Jan 2022 9:00 AM ISTWashington: Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the...
Today's neglected infectious diseases may be tomorrow's pandemic: Bharat Biotech Chief Ruchika Sharma26 Jan 2022 10:00 AM ISTNew Delhi: Bharat Biotech International Limited Chairman Dr Krishna Ella on Monday said today's neglected infectious diseases could be tomorrow's...
Sinovac CoronaVac shot gets strong boost from Pfizer, AstraZeneca, JnJ COVID doses, claims study Ruchika Sharma26 Jan 2022 10:00 AM ISTNew Delhi: A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels...
Gilead Sciences Remdesivir gets USFDA nod to treat non-hospitalized COVID patients Ruchika Sharma25 Jan 2022 1:48 PM ISTFoster City: Gilead Sciences, Inc. has recently announced that the U.S. Food and Drug Administration (USFDA) has granted expedited approval of a...
USFDA halts use of Regeneron, Lilly Covid-19 antibody treatments Ruchika Sharma25 Jan 2022 11:52 AM ISTNew Delhi: The U.S. health regulator revised on Monday the emergency use authorizations for COVID-19 antibody treatments from Regeneron and Eli...
Strides Pharma, Medicines Patent Pool ink pact to commercialize molnupiravir for global markets Ruchika Sharma24 Jan 2022 9:00 AM ISTBengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has recently announced its partnership with Medicines Patent Pool (MPP)...
Moderna to come up with combined COVID, flu booster by 2023 MD Bureau21 Jan 2022 10:00 AM ISTWashington: US drugmaker Moderna is working on a combined Covid-19 and flu booster shot, which could be available in some countries by fall 2023 at...
Pfizer to add production facility for antiviral COVID pill in France Dr. Divya Colin20 Jan 2022 9:15 AM ISTNew Delhi: Pfizer will add a production facility for its antiviral COVID-19 pill in France as part of a plan to invest 520 million euros ($594...
Sputnik V 75 percent effective against Omicron: Vaccine developer Ruchika Sharma20 Jan 2022 9:00 AM ISTMoscow: The effectiveness of the Sputnik V Covid-19 vaccine against the Omicron coronavirus variant is 75 per cent, Alexander Gintsburg, the head of...
